- Pharmacokinetics & Pharmacodynamics
- PBPK modeling and simulation
- Drug interactions
- Computational medicine
- In silico pharmacology
- Computational oncology
- Development and validation of bioanalytical methods
- Personalized/Stratified medicine
- Pharmaceutical care
- eHealth platforms and tools for pharmaceutical care
Participation in Research Projects
- SpeechXRays: Multi-channel biometrics combining acoustic and machine vision analysis of speech, lip movement and face [H2020-DS-2014-2015. No 653586]
- MHA: MyHealthAvatar:A Demonstration of 4D Digital Avatar Infrastructure for Access of Complete Patient Information [FP7-ICT-2011.5.2 (600929)].
- CHIC: Computational Horizons in Cancer: Developing Meta- and Hyper-Multiscale Models and Repositories for In Silico Oncology. [FP7-ICT-2011.5.2 (600841)].
Dr. Marios Spanakis is a collaborative researcher with the Computational BioMedicine Laboratory (CBML) in the Institute of Computer Science of the Foundation for Research & Technology - Hellas (FORTH). He holds a B.Sc. and a Ph.D. in Pharmacy from the School of Pharmacy of Aristotle University of Thessaloniki. The diversified knowledge, specialization and research interests revolve around the wide scientific domain of Pharmacology and mainly on Pharmacokinetics (PK) and Pharmacodynamics (PD). In CBML his research activities are related with computational medicine and in silico pharmacology. His research is focused on the assessment of physiologically based models for evaluation of PK/PD profiles of drugs and imaging biomarkers towards novel approaches of personalized and stratified medicine. Furthermore, his pharmaceutical background and expertise in pharmacology is utilized in CBML regarding the development of innovative personalized health services for achieving optimum therapeutic outcomes toward patient’s health and quality of life. Till today, his research findings have been published in a series of peer-reviewed international journals and conferences and have gain attention from the scientific community with more than 200 citations.